DRWF gain quality assurance for diabetes information
DRWF has been awarded the ‘Information Standard’ accreditation, developed by the Department of Health, which certifies its diabetes information as being trustworthy and reliable for
DRWF has been awarded the ‘Information Standard’ accreditation, developed by the Department of Health, which certifies its diabetes information as being trustworthy and reliable for
GlaxoSmithKline says that Otelixizumab, a Type 1 drug currently under development, has failed in a phase III clinical trial. The drug has been in development
JDRF has a ‘Type 1 diabetes symptoms’ posters which you can apply for and have sent to your local doctor’s surgery for them to display.
Research recently published in the The Lancet has indicated that early studies into a new basal insulin option for people with type 2 diabetes, which
Researchers are saying that ultra-tight blood sugar control in Type 2 diabetics considered to be high-risk patients may not necessarily be a good thing, according
The Royal College of Nursing (RCN) are seeking patients’ views and opinions about the care they receive from clinical nurse specialists and nurse consultants, and
Researchers say they have discovered a new way in which beta cells in the pancreas are destroyed, according to a recent article posted on dLife.
Just as we start to get a little bit of sunshine, new research out of Iran suggests that vitamin D may help people with Type
Doctors often fail to diagnose Type 1 diabetes in children until the symptoms are severe, according to a recent article from the Press Association. Most
Hypo-Fit syrup 74.5% is a premium product, which is a unique combination of three sugars (glucose, saccharose (sucrose) and fructose), water and flavouring (available in